ELUTIA INC. - CLASS A COMMON STOCK

Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study

28 4 2021 16:05:01 提供 Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit

26 4 2021 16:05:00 提供 Nasdaq GlobeNewswire

Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

20 4 2021 16:05:00 提供 Nasdaq GlobeNewswire

Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

01 3 2021 16:05:00 提供 Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Cowen 41st Annual Health Care Conference

18 2 2021 16:05:01 提供 Nasdaq GlobeNewswire

Aziyo Biologics Announces First Patient Enrolled in HEAL Study

17 2 2021 16:05:00 提供 Nasdaq GlobeNewswire

Aziyo Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021

15 2 2021 12:00:00 提供 Nasdaq GlobeNewswire

Aziyo Biologics Announces Product Design Completion for its Next Generation CanGaroo® Envelope for Implantable Electronic Devices

11 2 2021 16:05:00 提供 Nasdaq GlobeNewswire

Aziyo Biologics Announces Updated CanGaroo® Envelope Label in European Markets to Allow for Hydration in an Antibiotic Solution

28 1 2021 16:05:01 提供 Nasdaq GlobeNewswire